Clinical immunology (Orlando, Fla.)HumansMyasthenia GravisAntibodiesMonoclonalHumanized
Eculizumab as a new option for perioperative treatment in thymoma-associated myasthenia gravis.
Hui Wu, Xianglin Chu, Huahua Zhong, Ying Huang, Hongxia Yang, Guoyan Qi, Lei Jin, Ran Chen, Wenji Jia, Ji Xiong, Liewen Pang, Chongbo Zhao, Jie Song, Sushan Luo
Published: 202610.1016/j.clim.2025.110657
Abstract
The efficacy of eculizumab as a perioperative treatment in patients with thymoma-associated myasthenia gravis (TAMG) has not been evaluated. This prospective study included patients with TAMG who received standard-of-care therapy (Soc group, n = 20)…
Preview only. Read the full abstract at the source